Variant report
Variant | rs1800481 |
---|---|
Chromosome Location | chr2:21267210-21267211 |
allele | C/T |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:21265200-21268400 | Enhancers | Spleen | Spleen |
2 | chr2:21265800-21267600 | Bivalent Enhancer | Fetal Stomach | stomach |
3 | chr2:21266000-21268400 | Enhancers | Lung | lung |
4 | chr2:21266200-21267400 | Bivalent/Poised TSS | ES-I3 Cell Line | embryonic stem cell |
5 | chr2:21266200-21267400 | Bivalent/Poised TSS | HUES64 Cell Line | embryonic stem cell |
6 | chr2:21266400-21267400 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
7 | chr2:21266400-21267800 | Bivalent Enhancer | Primary hematopoietic stem cells | blood |
8 | chr2:21266800-21267600 | Weak transcription | Right Ventricle | heart |
9 | chr2:21266800-21270200 | Weak transcription | Ovary | ovary |
10 | chr2:21267000-21267400 | Bivalent/Poised TSS | HUES48 Cell Line | embryonic stem cell |
11 | chr2:21267000-21267400 | Flanking Active TSS | Fetal Intestine Small | intestine |
12 | chr2:21267000-21267600 | Bivalent/Poised TSS | iPS-18 Cell Line | embryonic stem cell |
13 | chr2:21267000-21267600 | Bivalent Enhancer | Placenta | Placenta |
14 | chr2:21267000-21267800 | Weak transcription | Left Ventricle | heart |
15 | chr2:21267000-21268000 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
16 | chr2:21267000-21268400 | Enhancers | Adipose Nuclei | Adipose |
17 | chr2:21267000-21270000 | Weak transcription | Gastric | stomach |
18 | chr2:21267200-21267400 | Flanking Bivalent TSS/Enh | H1 Cell Line | embryonic stem cell |
19 | chr2:21267200-21267400 | Flanking Active TSS | H9 Cell Line | embryonic stem cell |
20 | chr2:21267200-21267400 | Bivalent Enhancer | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
21 | chr2:21267200-21267400 | Flanking Bivalent TSS/Enh | HUES6 Cell Line | embryonic stem cell |
22 | chr2:21267200-21267400 | Flanking Bivalent TSS/Enh | iPS-20b Cell Line | embryonic stem cell |
23 | chr2:21267200-21267400 | Flanking Active TSS | iPS DF 6.9 Cell Line | embryonic stem cell |
24 | chr2:21267200-21267400 | Flanking Active TSS | iPS DF 19.11 Cell Line | embryonic stem cell |
25 | chr2:21267200-21267600 | Flanking Bivalent TSS/Enh | iPS-15b Cell Line | embryonic stem cell |
26 | chr2:21267200-21267600 | Bivalent/Poised TSS | Duodenum Mucosa | Duodenum |
27 | chr2:21267200-21267600 | Flanking Active TSS | Fetal Intestine Large | intestine |
28 | chr2:21267200-21268200 | Flanking Active TSS | HepG2 | liver |
29 | chr2:21267200-21268400 | Bivalent Enhancer | ES-WA7 Cell Line | embryonic stem cell |
30 | chr2:21267200-21268400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
31 | chr2:21267200-21268600 | Flanking Active TSS | Liver | Liver |